# Boron Neutron Capture Therapy (BNCT) Combined With Cetuximab in the Treatment of Locally Recurred Head and Neck Cancer

> **NCT00927147** · PHASE1,PHASE2 · TERMINATED · sponsor: **Boneca Corporation** · enrollment: 17 (actual)

## Conditions studied

- Head and Neck Cancer

## Interventions

- **RADIATION:** BNCT
- **DRUG:** cetuximab

## Key facts

- **NCT ID:** NCT00927147
- **Lead sponsor:** Boneca Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-06
- **Primary completion:** 2013-06
- **Final completion:** 2013-06
- **Target enrollment:** 17 (ACTUAL)
- **Why stopped:** The neutron facility closed down for financial reasons.
- **Last updated:** 2017-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00927147

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00927147, "Boron Neutron Capture Therapy (BNCT) Combined With Cetuximab in the Treatment of Locally Recurred Head and Neck Cancer". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT00927147. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*